North West University
Master of Pharmacy in Pharmacy Practice with Pharmacovigiliance and Pharmacoepidemiology
The Master of Pharmacy in Pharmacy Practice with Pharmacovigiliance and Pharmacoepidemiology in Pharmacy is offered by North West University.
Program Length: 1 YEAR.
Subjects: 5.
Master of Pharmacy in Pharmacy Practice with Pharmacovigiliance and Pharmacoepidemiology offered by the North West University at the Faculty of Health Sciences
Outcomes of the qualification
After completion of the qualification the student will be able to:
a) demonstrate advanced, systematic and specialist knowledge and skill to undertake a focused literature review, identify a relevant research problem and related research questions and apply appropriate research methods and techniques within the field of medicine utilisation and pharmacy practice;
b) plan and execute suitable quantitative and/or qualitative research approaches in a scientific and ethical manner by making use of appropriate research methods, techniques and procedures;
c) interpret and integrate research findings and recommendations in a scientifically accountable manner and, via scientific and ethically correct verbal and written communication, present the complete dissertation to the appointed examiners; and
d) act as a leader, i.e. ethically and responsibly, in the pharmaceutical profession as far as appropriate medicine utilisation and pharmacy practice is concerned.
Duration (Minimum and maximum)
The minimum duration for the study is one year and the maximum duration two years, calculated from the date of first registration for the particular programme. The faculty’s 75 decision is based on the current subsidy model for universities and may differ from other faculties or regulations.
Programme: (with) Pharmacovigiliance and Pharmacoepidemiology
The purpose of the programme is to equip postgraduate students to be capable of practising at a highly specialised level as pharmacists who can act as role models in both the performance and future development of pharmacy practice, pharmacovigilance and pharmacoepidemiology. This qualification also aims to prepare graduates for further study at NQF level 10.
The programme is presented on a full time and part time basis in Afrikaans and English. Applications close 30 September.
Programe-specific outcomes:
Upon completion of the programme, the student should be able to demonstrate:
a) The ability to apply specialized knowledge and professional skills to understand issues surrounding the risks and benefits of drug use in humans and the implementing of pharmacovigilance programmes in health care environments;
b) The ability to evaluate current processes of knowledge production within the field of drug safety, medicine consumption and pharmacovigilance and then to identify an appropriate research question to address a specific problem in it.
c) Under supervision, the ability to identify, conceptualise, design and implement a quantitative and/or qualitative pharmacoepidemiological study in a scientific and ethical manner to address complex and challenging problems within drug safety, medicine consumption and pharmacovigilance.
d) An ability to make autonomous ethical decisions which affect the safe use of medicine and the practice of pharmacovigilance.
e) An ability to design and implement a strategy for the processing and management of information, in order to conduct a comprehensive review of leading and current research within drug safety and medicine consumption to produce significant insights into pharmacovigilance.
f) Interpret and integrate research results in a scientifically accountable manner, and in a scientific and ethical way communicate results - orally and in writing.
g) Refer to e and f.
h) Ability to be self-directed and a lifelong learner, able to work independently, utilise resources effectively, and exercise initiative in the field of medicine consumption, drug safety and pharmacovigilance.
i) Intellectual independence, research leadership and management of research and research development as far as appropriate and safe medicine consumption in South Africa and surrounding countries is concerned.
Curriculum
Year module:
Dissertation (116 credits)
First semester:
Research methodology, biostatistics and evidence-based practice for health professionals (16 credits)
Adverse drug reactions and drug-related problems (16 credits)
Second semester:
Advanced drug utilization review and pharmacoepidemiology (16 credits)
Pharmacovigilance (16 credits)
